Vanda Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell VNDA and other ETFs, options, and stocks.

About VNDA

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. 

CEO
Mihael Hristos Polymeropoulos
CEOMihael Hristos Polymeropoulos
Employees
368
Employees368
Headquarters
Washington, District of Columbia
HeadquartersWashington, District of Columbia
Founded
2002
Founded2002
Employees
368
Employees368

VNDA Key Statistics

Market cap
361.97M
Market cap361.97M
Price-Earnings ratio
-1.64
Price-Earnings ratio-1.64
Dividend yield
Dividend yield
Average volume
1.25M
Average volume1.25M
High today
$6.29
High today$6.29
Low today
$6.04
Low today$6.04
Open price
$6.08
Open price$6.08
Volume
721.02K
Volume721.02K
52 Week high
$9.60
52 Week high$9.60
52 Week low
$3.81
52 Week low$3.81

Stock Snapshot

As of today, Vanda Pharmaceuticals(VNDA) shares are valued at $6.13. The company's market cap stands at 361.97M, with a P/E ratio of -1.64.

During the trading session on 2026-02-13, Vanda Pharmaceuticals(VNDA) shares reached a daily high of $6.29 and a low of $6.04. At a current price of $6.13, the stock is +1.4% higher than the low and still -2.6% under the high.

Trading activity shows a volume of 721.02K, compared to an average daily volume of 1.25M.

The stock's 52-week range extends from a low of $3.81 to a high of $9.60.

The stock's 52-week range extends from a low of $3.81 to a high of $9.60.

VNDA News

TipRanks 13h
Regulatory Hurdles Cloud Vanda Pharmaceuticals’ Prospects for Bysanti and Imsidolimab FDA Approvals

Vanda Pharmaceuticals (VNDA) has disclosed a new risk, in the Regulation category. Vanda Pharmaceuticals faces significant uncertainty in obtaining FDA approva...

TipRanks 2d
Vanda Pharmaceuticals reports Q4 EPS ($2.39) vs. (8c) last year

Reports Q4 revenue $57.2M, consensus $59.27M. “2025 showed strong momentum at Vanda, led by Fanapt, with net product sales up 24% to $117.3 million, driven by a...

People also own

Based on the portfolios of people who own VNDA. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.